Ustyugova相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines

利用新一代流感疫苗增强血凝素存在下的神经氨酸酶免疫力

期刊:NPJ Vaccines

影响因子:6.5

doi:10.1038/s41541-024-01011-x

Cortés, Guadalupe; Ustyugova, Irina; Farrell, Timothy; McDaniel, Clint; Britain, Colleen; Romano, Christopher; N'Diaye, Siré; Zheng, Lingyi; Ferdous, Mithila; Iampietro, Justin; Pougatcheva, Svetlana; La Rue, Lauren; Han, Liqun; Ma, Fuqin; Stegalkina, Svetlana; Ray, Satyajit; Zhang, Jianxin; Barro, Mario

免疫/内分泌

发表日期：2024

文献求助收藏

The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017

2009 年至 2017 年人类流感 N2 神经氨酸酶的抗原概况

影响因子:6.4

doi:10.7554/eLife.90782

João Paulo Portela Catani, Anouk Smet, Tine Ysenbaert, Marnik Vuylsteke, Guy Bottu, Janick Mathys, Alexander Botzki, Guadalupe Cortes-Garcia, Tod Strugnell, Raul Gomila, John Hamberger, John Catalan, Irina V Ustyugova, Timothy Farrell, Svetlana Stegalkina, Satyajit Ray, Lauren LaRue, Xavier Saelens,

发表日期：2024

文献求助收藏

Formulation development of a stable influenza recombinant neuraminidase vaccine candidate

稳定型流感重组神经氨酸酶候选疫苗的制剂开发

期刊:Human Vaccines & Immunotherapeutics

影响因子:3.5

doi:10.1080/21645515.2024.2304393

Li, Bing; Ustyugova, Irina V; Szymkowicz, Lisa; Zhu, Shaolong; Ming, Marin; Fung, Karen Y Y; Cortés, Guadalupe; James, D Andrew; Hrynyk, Michael; Rahman, Nausheen; Brookes, Roger H; Ausar, Salvador F

发表日期：2024

文献求助收藏

Cost-Effectiveness of Empagliflozin (JARDIANCE(®)) in the Treatment of Patients with Chronic Kidney Disease in France, Based on the EMPA-KIDNEY Clinical Trial

基于 EMPA-KIDNEY 临床试验，评估恩格列净 (JARDIANCE®) 在法国治疗慢性肾病患者的成本效益

期刊:Clinical Drug Investigation

影响因子:2.7

doi:10.1007/s40261-024-01398-4

Groyer, Harinala; Supiot, Romain; Tardu, Jean; Virely, Nicolas; Sivignon, Marine; San, Denis; Lévy, Pierre; Ustyugova, Anastasia; Massy, Ziad A

发表日期：2024

文献求助收藏

Empagliflozin reduces cardiorenal events, healthcare resource use and mortality in Sweden compared to dipeptidyl peptidase-4 inhibitors: Real world evidence from the Nordic EMPRISE study

与二肽基肽酶-4抑制剂相比，恩格列净可降低瑞典患者的心肾事件、医疗资源使用和死亡率：来自北欧EMPRISE研究的真实世界证据

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.14870

Nyström, Thomas; Toresson Grip, Emilie; Gunnarsson, Joel; Casajust, Paula; Karlsdotter, Kristina; Skogsberg, Josefin; Ustyugova, Anastasia

发表日期：2023

文献求助收藏

Healthcare resource utilization in patients treated with empagliflozin in East Asia

东亚地区接受恩格列净治疗的患者的医疗资源利用情况

期刊:Journal of Diabetes Investigation

doi:10.1111/jdi.13728

Sheu, Wayne H-H; Seino, Yutaka; Tan, Elise Chia-Hui; Yabe, Daisuke; Ha, Kyoung Hwa; Nangaku, Masaomi; Chung, Wook-Jin; Node, Koichi; Yasui, Atsutaka; Lei, Wei-Yu; Lee, Sunwoo; Ustyugova, Anastasia; Klement, Riho; Deruaz-Luyet, Anouk; Kyaw, Moe H; Kim, Dae Jung

发表日期：2022

文献求助收藏

Healthcare Resource Utilization and Costs for Empagliflozin Versus Glucagon-Like Peptide-1 Receptor Agonists in Routine Clinical Care in Denmark

丹麦常规临床护理中恩格列净与胰高血糖素样肽-1受体激动剂的医疗资源利用和成本比较

期刊:Diabetes Therapy

影响因子:2.6

doi:10.1007/s13300-022-01323-y

Thomsen, Reimar W; Christensen, Lotte W B; Kahlert, Johnny; Knudsen, Jakob S; Ustyugova, Anastasia; Sandgaard, Susanne; Holmgaard, Pia; Ehlers, Lars H; Sørensen, Henrik T

发表日期：2022

文献求助收藏

Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans

老年人接种流感疫苗可增强针对保守病毒蛋白和鸡蛋产生的聚糖的抗体

期刊:Journal of Clinical Investigation

影响因子:13.3

doi:10.1172/JCI148763

Jiwon Jung, Sophia T Mundle, Irina V Ustyugova, Andrew P Horton, Daniel R Boutz, Svetlana Pougatcheva, Ponraj Prabakaran, Jonathan R McDaniel, Gregory R King, Daechan Park, Maria D Person, Congxi Ye, Bing Tan, Yuri Tanno, Jin Eyun Kim, Nicholas C Curtis, Joshua DiNapoli, Simon Delagrave, Ted M Ross,

发表日期：2021

文献求助收藏

Cardiovascular Events, Acute Hospitalizations, and Mortality in Patients With Type 2 Diabetes Mellitus Who Initiate Empagliflozin Versus Liraglutide: A Comparative Effectiveness Study

恩格列净与利拉鲁肽治疗2型糖尿病患者的心血管事件、急性住院和死亡率：一项比较疗效研究

期刊:Journal of the American Heart Association

影响因子:5.3

doi:10.1161/JAHA.120.019356

Thomsen, Reimar W; Knudsen, Jakob S; Kahlert, Johnny; Baggesen, Lisbeth M; Lajer, Maria; Holmgaard, Pia H; Vedin, Ola; Ustyugova, Anastasia; Sørensen, Henrik T

发表日期：2021

文献求助收藏

Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease

在患有 2 型糖尿病和已确诊心血管疾病的患者中，恩格列净与卡格列净、达格列净或标准治疗方案相比的成本效益分析

期刊:Bmj Open Diabetes Research & Care

影响因子:4.1

doi:10.1136/bmjdrc-2020-001313

Reifsnider, Odette S; Kansal, Anuraag R; Gandhi, Pranav K; Cragin, Lael; Brand, Sarah B; Pfarr, Egon; Fahrbach, Kyle; Ustyugova, Anastasia

心血管疾病

发表日期：2021

文献求助收藏